US Equities
Palisade Bio, Inc. (PALI) Stock Surged 67.07% Today, Here’s Why
Palisade Bio, Inc. (PALI) stock soared 67.07% in the current-market trading session at the price of $1.34 after it received a letter from FDA to proceed with its clinical trial evaluating LB1148. PALI is a clinical-stage biopharma firm. It produces novel therapies to treat patients
